<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T06:12:44Z</responseDate>
  <request identifier="oai:figshare.com:article/33812807" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33812807</identifier>
        <datestamp>2026-09-15T17:47:11Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Characteristics of EBVnGC patients and EBVaGC patients.&lt;/p&gt;</dc:title>
          <dc:creator>Peilin Wu (10998894)</dc:creator>
          <dc:creator>Xiazhen Xu (21417521)</dc:creator>
          <dc:creator>Qiong Wu (84327)</dc:creator>
          <dc:creator>Lu Zhang (50563)</dc:creator>
          <dc:creator>Fan Xin (14494955)</dc:creator>
          <dc:creator>Xiaowei Zheng (544070)</dc:creator>
          <dc:creator>Xu Lin (36043)</dc:creator>
          <dc:creator>Wannan Chen (6747332)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>&gt;, thereby regulating</dc:subject>
          <dc:subject>3 ′ utr</dc:subject>
          <dc:subject>preclinical therapeutic strategy</dc:subject>
          <dc:subject>including nasopharyngeal carcinoma</dc:subject>
          <dc:subject>oncogenic dna virus</dc:subject>
          <dc:subject>including cell proliferation</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>previously unrecognized ebv</dc:subject>
          <dc:subject>associated gastric cancer</dc:subject>
          <dc:subject>5p directly targets</dc:subject>
          <dc:subject>akt signaling activation</dc:subject>
          <dc:subject>ebv cells rescues</dc:subject>
          <dc:subject>gastric carcinoma</dc:subject>
          <dc:subject>cell proliferation</dc:subject>
          <dc:subject>akt signaling</dc:subject>
          <dc:subject>etiologically associated</dc:subject>
          <dc:subject>barr virus</dc:subject>
          <dc:subject>snu719 cells</dc:subject>
          <dc:subject>ebv cells</dc:subject>
          <dc:subject>xenograft models</dc:subject>
          <dc:subject>therapeutic potential</dc:subject>
          <dc:subject>systemic administration</dc:subject>
          <dc:subject>suppressive mirna</dc:subject>
          <dc:subject>similar results</dc:subject>
          <dc:subject>significantly downregulated</dc:subject>
          <dc:subject>pathogenic functions</dc:subject>
          <dc:subject>multiple malignancies</dc:subject>
          <dc:subject>mirnas ),</dc:subject>
          <dc:subject>mechanistic analyses</dc:subject>
          <dc:subject>inversely correlates</dc:subject>
          <dc:subject>inhibitory effects</dc:subject>
          <dc:subject>findings reveal</dc:subject>
          <dc:subject>engineered cholesterol</dc:subject>
          <dc:subject>encoded microrna</dc:subject>
          <dc:description>&lt;p&gt;Characteristics of EBVnGC patients and EBVaGC patients.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T17:46:48Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.ppat.1014519.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Characteristics_of_EBVnGC_patients_and_EBVaGC_patients_p_/33812807</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
